Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data
暂无分享,去创建一个
Alejandro Sifrim | Matthew E Hurles | Tomas W. Fitzgerald | Diana Rajan | Susan Gribble | Caroline F Wright | Eleni A. Chatzimichali | Vijaya Parthiban | Stephen Clayton | Wendy D Jones | Eugene Bragin | Anna Middleton | Michael Parker | Nigel P Carter | G Jawahar Swaminathan | Elena Prigmore | Katherine I Morley | G. J. Swaminathan | Jeffrey C Barrett | T. Fitzgerald | N. Carter | M. Hurles | J. Barrett | H. Firth | S. Gribble | A. Tivey | E. Prigmore | A. Middleton | J. McRae | K. Morley | V. Parthiban | D. Fitzpatrick | C. Wright | A. Bevan | M. Parker | A. Sifrim | K. Ambridge | M. van Kogelenberg | T. Bayzetinova | S. Clayton | N. Krishnappa | D. Rajan | E. Bragin | Philip Jones | W. Jones | D. King | D. Barrett | L. E. Mason | Ray Miller | David R FitzPatrick | Helen V Firth | Jeremy F McRae | Tomas W Fitzgerald | Margriet van Kogelenberg | Daniel A King | Kirsty Ambridge | Daniel M Barrett | Tanya Bayzetinova | A Paul Bevan | Eleni A Chatzimichali | Philip Jones | Netravathi Krishnappa | Laura E Mason | Ray Miller | Adrian R Tivey | M. Kogelenberg | P. Jones | A. P. Bevan | D. FitzPatrick | G. Swaminathan
[1] Muin J Khoury,et al. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.
[2] Robert C. Green,et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets , 2012, Genetics in Medicine.
[3] Jennifer D. Churchill,et al. Exome-based mapping and variant prioritization for inherited Mendelian disorders. , 2014, American journal of human genetics.
[4] Tomas W. Fitzgerald,et al. Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.
[5] Jana Marie Schwarz,et al. MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.
[6] Claire Redin,et al. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. , 2013, American journal of human genetics.
[7] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[8] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[9] M. Hurles,et al. Empirical research on the ethics of genomic research , 2013, American journal of medical genetics. Part A.
[10] Emily H Turner,et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.
[11] D. G. MacArthur,et al. Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.
[12] W P Robinson,et al. Mechanisms leading to uniparental disomy and their clinical consequences , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[14] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[15] Caroline F. Wright,et al. DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation , 2013, Nucleic Acids Res..
[16] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[17] E. Birney,et al. Policy challenges of clinical genome sequencing , 2013, BMJ.
[18] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[19] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[20] Arthur Wuster,et al. DeNovoGear: de novo indel and point mutation discovery and phasing , 2013, Nature Methods.
[21] D. Goldstein,et al. Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.
[22] Tomas W. Fitzgerald,et al. A novel method for detecting uniparental disomy from trio genotypes identifies a significant excess in children with developmental disorders , 2014, Genome research.
[23] Charles A. Nelson,et al. The incidentalome. , 2006, JAMA.
[24] M. Hurles,et al. No expectation to share incidental findings in genomic research , 2015, The Lancet.
[25] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[26] Sylvia Stockler,et al. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. , 2012, Molecular genetics and metabolism.
[27] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[28] R. Durbin,et al. Dindel: accurate indel calls from short-read data. , 2011, Genome research.
[29] R. Altman,et al. The incidentalome: a threat to genomic medicine. , 2006, JAMA.
[30] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[31] Soma Das,et al. Exome sequencing and the genetics of intellectual disability , 2011, Clinical genetics.
[32] David P Bick,et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.
[33] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[34] Jay Shendure,et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2012, Nature Genetics.
[35] B. Berkman,et al. Do Researchers Have an Obligation to Actively Look for Genetic Incidental Findings? , 2013, The American journal of bioethics : AJOB.
[36] P. Stankiewicz,et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.
[37] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[38] H. Firth,et al. The Deciphering Developmental Disorders (DDD) study , 2011, Developmental medicine and child neurology.
[39] C. Shaw-Smith,et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects , 2009, Genetics in Medicine.
[40] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[41] S. Mundlos,et al. The Human Phenotype Ontology , 2010, Clinical genetics.
[42] M. Rieder,et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.
[43] R. Reading,et al. Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .
[44] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .